Showing results (311-320 of 969) with videos related to
Sort By:
Pageof 97
Journal of Drugs in Dermatology : JDD|November 9, 2023
Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-SeriesBrittany Baroudi, Arjun M Bashyam, Steven R Feldman, et al.Expert Review of Pharmacoeconomics & Outcomes Research|October 22, 2015
The cost-effectiveness of ustekinumab for moderate-to-severe psoriasisNicole C Rouse, Michael E Farhangian, Brooke Wehausen, et al.The Journal of Dermatological Treatment|November 3, 2009
Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptomsSarah L Taylor, Matthew Petrie, Kenneth S O'Rourke, et al.Journal of the American Academy of Dermatology|December 1, 2009
Factors affecting sleep quality in patients with psoriasisSmitha Gowda, Orin M Goldblum, W Vaughn McCall, et al.Workplace Health & Safety|July 3, 2015
A Review of Patient Lifting Interventions to Reduce Health Care Worker InjuriesImran Aslam, Scott A Davis, Steven R Feldman, et al.Dermatology Online Journal|November 9, 2004
A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patientsB Asher Louden, Daniel J Pearce, Wei Lang, et al.The Journal of Dermatological Treatment|January 9, 2010
Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United StatesAli Alikhan, Meaghan Daly, Jun Wu, et al.Journal of the National Medical Association|April 21, 2021
How the National Ambulatory Medical Care Survey has been used to identify health disparities in the care of patients in the United StatesAmanda S Weissman, Varun Ranpariya, Alan B Fleischer, et al.Dermatology Online Journal|November 19, 2019
The rise in subscription skin care servicesMichael J Visconti, Wasim Haidari, Steven R Feldman, et al.Clinical and Experimental Dermatology|July 30, 2025
Greater topical corticosteroid quantity applied reduces severity of psoriasis: Results from two randomized controlled trialsMathias Tiedemann Svendsen, Sören Möller, Steven R Feldman, et al.Pageof 97